Human arteries engineered in vitro. - Wikidata - awgldk - TriplyDB

Human arteries engineered in vitro.

Human arteries engineered in vitro.

http://www.wikidata.org/entity/Q34236694

about

Therapeutic Targeting of Telomerase Capture of endothelial cells under flow using immobilized vascular endothelial growth factor The Tissue-Engineered Vascular Graft-Past, Present, and Future.Current advances in research and clinical applications of PLGA-based nanotechnology.Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media Arterial graft with elastic layer structure grown from cells Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells.Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues.Utility of telomerase-pot1 fusion protein in vascular tissue engineering.Hemodynamics and axial strain additively increase matrix remodeling and MMP-9, but not MMP-2, expression in arteries engineered by directed remodeling.Bioengineered vascular graft grown in the mouse peritoneal cavity.Biomaterials for vascular tissue engineering Molecular and functional effects of organismal ageing on smooth muscle cells derived from bone marrow mesenchymal stem cells.Relevance and safety of telomerase for human tissue engineering.Tissue engineering of blood vessel.Vascular engineering for bypass surgery.Tissue Engineering of Blood Vessels: Functional Requirements, Progress, and Future Challenges.Vascular grafts and the endothelium.Histological and mechanical properties of autologous living tissue biotubes.Human mesenchymal stem cells: from basic biology to clinical applications.Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs).Polymeric materials for tissue engineering of arterial substitutes.Influence of culture medium on smooth muscle cell differentiation from human bone marrow-derived mesenchymal stem cells.Cell division cycle 7 mediates transforming growth factor-β-induced smooth muscle maturation through activation of myocardin gene transcription.Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery.Response of mesenchymal stem cells to shear stress in tissue-engineered vascular grafts The evolution of vascular tissue engineering and current state of the art.Reverse engineering the mechanical and molecular pathways in stem cell morphogenesis.Arterial tissue regeneration for pediatric applications: inspiration from up-to-date tissue-engineered vascular bypass grafts.Small-diameter vascular tissue engineering.Evaluation of late outgrowth endothelial progenitor cell and umbilical vein endothelial cell responses to thromboresistant collagen-mimetic hydrogels.Perivascular cells and tissue engineering: Current applications and untapped potential Cell-free vascular grafts: Recent developments and clinical potential.Biomaterials patterned with discontinuous microwalls for vascular smooth muscle cell culture: biodegradable small diameter vascular grafts and stable cell culture substrates.Bypassing the patient: comparison of biocompatible models for the future of vascular tissue engineering.p42/p44 MAP kinase activation is localized to caveolae-free membrane domains in airway smooth muscle.Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways.A new tissue-engineered biodegradable surgical patch for high-pressure systems †.Computational simulation of a magnetic microactuator for tissue engineering applications.The use of hTERT-immortalized cells in tissue engineering.

P2860

Q26741736-ED3BE20E-4EDA-4CF2-8317-C45D4D48C96C Q26782026-B3E9785A-02B0-407A-BC3C-415C35D75561 Q30385854-1AF9F8E5-8925-49BC-AD40-4FDF5C91976D Q30482916-6FBCFF20-647F-46E8-B8BA-32C95C0AE52D Q30499083-B0FB9E2D-FA0F-4CC1-9099-948D1FA438B1 Q30849415-4FA54A10-05C4-4B84-AB71-9F67F0691907 Q31005484-556264C7-1F9B-45EC-85B5-817F2C4A0350 Q33392869-18DC4A03-8495-446A-AEC6-6F659CFDAA8C Q33514152-0EB2FD75-E7CB-4993-8813-5F895529558A Q33606446-73AE08CC-15CD-4D5B-9F2D-1D6F93C3CB13 Q33652217-D16D4B0C-1CCA-4938-9B22-F4A0DC5496A1 Q33655808-001233ED-80A9-41A9-B3F8-CC8C98167D2F Q33906840-4906B536-71ED-4C49-B60E-AB3D5B57A79F Q34479476-8F87E28B-FAE9-47DC-B076-7E0153CF1C19 Q35459503-4F57FB94-7066-4F1D-AD89-B5FCCD31FC37 Q36216829-76E54942-72BA-4C38-8CFE-59CCC31F5819 Q36419601-63E0B62A-3C02-40B1-952D-1D2FE5AE5BFA Q36684468-43C12346-9498-43DE-B46C-97FFFF24B30D Q36986375-E7E44D29-1762-4968-AE15-556B1F368034 Q36996120-1E6C5FDA-CD8E-4DF3-804C-0F130045A0DC Q37021191-40365257-06B7-4419-9BE3-45A9FDA69524 Q37271721-CDB7FD63-A402-4C0F-8410-034705F729BA Q37276870-5153F403-B05A-4A95-B7BE-45DED69898F8 Q37348858-71EB823B-854B-42C3-A160-5514E2B6DAD4 Q37377991-BFE99B11-87F4-43EB-8C76-8B15F190F895 Q37728948-05B2E71F-0D8A-439F-99F4-63DEFBAD237F Q37945454-35019569-EA0D-487C-A780-2495FD7927E2 Q38074123-4AD343D3-ECBC-4C0F-939C-0A697E7A1770 Q38095588-AF1F2AA6-27E5-4565-96A1-9EB5359DC71C Q38108204-FC9B99F4-2036-4950-869A-36F8A8DCC7A0 Q38951940-A74A8D1B-B51D-47BF-8A59-30E935B93547 Q39020914-9D5D1C41-6209-4418-94BE-4DF4010823C0 Q39412909-D07A6843-EF01-4375-9226-410E4EFB9B3A Q39574262-04E6094D-BB7C-4A26-B976-F64CE00ACA96 Q39772975-47E9DF13-F985-4E44-B391-FBC29BD7DA62 Q40181310-BAD47F98-1B72-47B6-B636-EA77CE2FFBCF Q40275746-8A0C4A1C-46A9-4380-A0D9-EF8596D9775C Q41344611-D20D69B1-6366-4093-927F-A3345580925E Q42151057-F79CFFC2-F06E-4F0E-9E70-3B7BAD8F772A Q42206146-DB901A3C-EFE8-441D-A043-BF17C15D8C3C

P2860

Human arteries engineered in vitro.

http://www.wikidata.org/entity/Q34236694

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Human arteries engineered in vitro.

@ast

Human arteries engineered in vitro.

@en

Human arteries engineered in vitro.

@nl

type

label

Human arteries engineered in vitro.

@ast

Human arteries engineered in vitro.

@en

Human arteries engineered in vitro.

@nl

prefLabel

Human arteries engineered in vitro.

@ast

Human arteries engineered in vitro.

@en

Human arteries engineered in vitro.

@nl

P1433

Q34236694-03BC2586-019F-4FA2-A8A4-3180D87438C1

P1476

Q34236694-18EBF241-B5C3-4992-B393-8DB4EF538CD9

P2093

Q34236694-2213375A-4D7C-4B65-9389-AEE34289DBC6

Q34236694-29B51309-7090-4C6E-8EA8-183D86E7E1C5

Q34236694-369D1891-F37C-4FC2-94AB-72CF38D14394

Q34236694-37408825-5360-46A5-9760-FF1BF1C9C387

Q34236694-634FD2D0-FBE1-4C43-B9AA-D34B16120416

Q34236694-855D2D48-6AD9-4A6A-886F-2CDEAFF5B953

Q34236694-CAE6D0C7-76FA-43E0-BDE3-BB1A6F9954D7

P2860

Q34236694-0AC4972A-2E07-464D-BAEC-47AD5DDAD4D2

Q34236694-0B1A9A3F-7AC7-4573-9146-2770A5F1B3ED

Q34236694-1B1F3E49-E015-46E0-9843-9CB007EB1BDC

Q34236694-23E907E6-1806-49B5-AEF6-BB76A7D15D70

Q34236694-2CA9A5DF-60AA-47D5-9341-DBFEF5F8ED4A

Q34236694-33D70A84-5196-48E1-A22B-D089C46C6DAB

Q34236694-39DE2513-86E1-4264-AED3-ADD75E6F63E7

Q34236694-3BC3FA5D-510E-4350-BF5E-48EAA803433E

Q34236694-40D2B4B2-E7F0-4C44-9C47-CE12B82D384F

Q34236694-5FA66F0A-BD47-4407-A3D9-1E36ED1FAFDA

P304

Q34236694-57DA7C62-48B2-4535-B952-11787FCF88A2

P31

Q34236694-7C70263E-B1B6-4CDD-8132-DCF56445D5A7

P356

Q34236694-ECEC02CF-1289-461D-A753-96D025E47010

P433

Q34236694-CAFCF2A8-AE07-4493-85A8-C7DEB295FCCE

P478

Q34236694-1ADB8A91-B3C6-4702-B6AC-A2766F219307

P577

Q34236694-25E3A7CA-7DDB-41F4-BC36-6D89CC161B38

P5875

Q34236694-E287753D-C73C-4F32-83B4-207A2A9B4D44

P698

Q34236694-94735D34-9019-4522-A639-2CA045A58B07

P932

Q34236694-98ABB806-116A-4926-941A-846A5FD6AEDF

P356

SJ.EMBOR.EMBOR847

P1433

P1476

Human arteries engineered in vitro.

@en

P2093

Christopher M Counter

http://www.w3.org/2001/XMLSchema#string

J Andrew McKee

http://www.w3.org/2001/XMLSchema#string

Jeffrey H Lawson

http://www.w3.org/2001/XMLSchema#string

Laura E Niklason

http://www.w3.org/2001/XMLSchema#string

Matthew J Boyer

http://www.w3.org/2001/XMLSchema#string

Nesrin M Hamad

http://www.w3.org/2001/XMLSchema#string

Soma S R Banik

http://www.w3.org/2001/XMLSchema#string

P2860

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization

Extension of life-span by introduction of telomerase into normal human cells

Creation of human tumour cells with defined genetic elements

A survey of telomerase activity in human cancer

Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity

Telomere length predicts replicative capacity of human fibroblasts

Tissue engineering

Regulation of differentiation of vascular smooth muscle cells.

Reversing time: origin of telomerase.

Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation.

P304

633-638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.EMBOR.EMBOR847

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10735088

http://www.w3.org/2001/XMLSchema#string

P698

12776184

http://www.w3.org/2001/XMLSchema#string

P932

1319197

http://www.w3.org/2001/XMLSchema#string